Effect of delays on survival in patients with lung cancer
- PMID: 21156415
- DOI: 10.1007/s12094-010-0606-5
Effect of delays on survival in patients with lung cancer
Abstract
Background: The effect on survival of delays in the consultation, diagnostic and treatment processes of lung cancer (LC) is still under debate. The objective of our study was to analyse these time delays and their possible effect on survival.
Methods: A retrospective study has been performed on all patients in our health area diagnosed with LC (confirmed by cytohistology) over 3 years. The delay in specialist consultation (time between start of symptoms and the first consultation with a specialist), hospital delay (time between first consultation and start of treatment) and overall delay (the sum of the previous two delays) were analysed. The influence of each of these delays was calculated using Cox regression, adjusted for other factors.
Results: A total of 415 patients were included. Of these, 92.5% were male and 75.4% were in stages III-B or IV. The overall delay gave a mean of 123.6 days, the delay in consulting a specialist 82.1 days and the delay in hospitalisation was 41.4 days. A greater overall delay or greater hospital delay was associated with longer survival. No relationship was observed between the specialist consultation delay and survival.
Conclusions: Globally analysing all the cases and all the stages with LC, it is seen that longer delays are associated with longer survival. This probably reflects the fact that patients with more symptoms are treated more rapidly.
Similar articles
-
Timeliness of care and prognosis in patients with lung cancer.Ir J Med Sci. 2014 Sep;183(3):383-90. doi: 10.1007/s11845-013-1025-8. Epub 2013 Oct 4. Ir J Med Sci. 2014. PMID: 24091615
-
Delays in the diagnosis and treatment of lung cancer.Chest. 2005 Oct;128(4):2282-8. doi: 10.1378/chest.128.4.2282. Chest. 2005. PMID: 16236885
-
Delays during the diagnostic evaluation and treatment of lung cancer.Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):453-6. Asian Pac J Cancer Prev. 2009. PMID: 19640190
-
Influence of delay on survival in patients with breast cancer: a systematic review.Lancet. 1999 Apr 3;353(9159):1119-26. doi: 10.1016/s0140-6736(99)02143-1. Lancet. 1999. PMID: 10209974
-
Impact of Delays in Lung Cancer Treatment on Survival.Chest. 2021 Nov;160(5):1934-1958. doi: 10.1016/j.chest.2021.08.051. Epub 2021 Aug 20. Chest. 2021. PMID: 34425080 Review.
Cited by
-
Waiting Time from Diagnosis to Treatment has no Impact on Survival in Patients with Esophageal Cancer.Ann Surg Oncol. 2016 Aug;23(8):2679-89. doi: 10.1245/s10434-016-5191-6. Epub 2016 Mar 24. Ann Surg Oncol. 2016. PMID: 27012988 Free PMC article.
-
Impact of Timeliness of Surgical Treatment on the Outcomes of Patients with Non-metastatic Non-small Cell Lung Cancer: Findings From the PLCO Trial.World J Surg. 2019 Nov;43(11):2927-2933. doi: 10.1007/s00268-019-05089-6. World J Surg. 2019. PMID: 31332492
-
Timeliness of Lung Cancer Diagnosis and Treatment.Fed Pract. 2017 Feb;34(Suppl 1):24S-29S. Fed Pract. 2017. PMID: 30766298 Free PMC article.
-
Timeliness of care and prognosis in patients with lung cancer.Ir J Med Sci. 2014 Sep;183(3):383-90. doi: 10.1007/s11845-013-1025-8. Epub 2013 Oct 4. Ir J Med Sci. 2014. PMID: 24091615
-
Importance of diagnosis-to-treatment interval in newly diagnosed patients with diffuse large B-cell lymphoma.Sci Rep. 2021 Feb 2;11(1):2837. doi: 10.1038/s41598-021-82615-4. Sci Rep. 2021. PMID: 33531642 Free PMC article.
References
MeSH terms
LinkOut - more resources
Medical